An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.
Investigational Treatment Gaining Popularity Online
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are urged to message these accounts directly for supplier links, while also receiving promotional offers.
Active Trade on Social Networks
Additionally, a robust trade exists on Telegram, where communities with numerous of members share “before and after” images, injection guides and claims of rapid UK delivery. Vendors promote the substance there before redirecting buyers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an experimental injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Experts Express Concerns
However, physicians and chemists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could result in users injecting products of unknown origin.
Several experts said the popularity for retatrutide could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.
Regulatory Status and Implementation
Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Several influencers try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach medicines, marketing, and customer laws, risking penalties, prosecution or imprisonment.
Service Reaction and Content Elimination
Based on TikTok, the platform has taken down problematic material and prohibited associated keywords and query recommendations. The organization said it was committed to keeping the service secure and allocating resources in strengthening compliance measures.
Digital Marketplace Operations
Investigations also found communities with up to nine thousand members marketing retatrutide using the platform's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with numerous of users, populated with photos of slimming results, positive reviews and detailed instructions for mixing or administering at home.
After moments of entering one group, a vendor shared contact information, where most transactions take place. The seller sent an guidebook and guaranteed delivery within two days. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about body mass, medical conditions or past usage.
Item Information and Costs
Inside these communities, posts display black plastic packages with Royal Mail stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with sterile water, or pre-filled injectors typically priced at £160 for 20mg. When questioned how long a injector should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Service Oversight and Security Measures
A representative for Telegram said it actively monitored dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering materials they can’t verify. Although the science behind this drug is sound, these digital products may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to current cost increases for approved slimming medications such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit injections are highly risky. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.
Her team has previously seen individuals injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a company investigational product not yet authorized … may expose patients to possibly serious health risks”.
